Building cannabis brands that reach across markets
The best cannabis brands find ways to connect, knowing their audience will choose brands that help them feel good about themselves, their communities and decisions.
Cannabis producer Organigram closes final tranche of CA$124.6M funding
Canadian cannabis producer Organigram Holdings closed on the final of three tranches of an overall investment of 124.6 million Canadian dollars (roughly $87 million) from a wholly owned subsidiary of British American Tobacco.
Greek cannabis operator Curity Pharma secures cultivation license
Greek cannabis operator Curity Pharma has been awarded a government operating license for a cultivation operation in the country.
MediPharm to sell British Columbia cannabis facility to Rubicon for $4.5M
Canadian cannabis company MediPharm Labs Corp. plans to sell its facility in Hope, British Columbia, to Rubicon Organics for $4.5 million in cash.
From client to co-founder, Storz & Bickel executive on US tour to drum up cannabis business
Co-founder Jürgen Bickel discusses Storz & Bickel’s rigorous testing protocols, the growth of Germany’s medical cannabis market and potential policy ramifications under the country’s newly elected conservative party.
Cannabis retailer High Tide rethinking acquisition of German operator
Canada-based cannabis retailer High Tide is stepping back from its deal with Purecan GmbH to enter Germany’s medical marijuana market.
Switzerland charts conservative course for adult-use cannabis legalization
In a significant step forward for cannabis legalization in Europe, a parliamentary commission in Switzerland has proposed a law that would allow regulated adult-use sales.
